U-cort
Loading...U-cort Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
U-cort®, (Hydrocortisone Acetate Cream USP, 1%) is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
History
There is currently no drug history available for this drug.
Other Information
Hydrocortisone Acetate Cream USP, 1% is intended for topical administration. The active component is the corticosteroid hydrocortisone acetate, which has the chemical name pregn-4-ene-3, 20-dione, 21-(acetyloxy)-11,17-dihydroxy-11β)-. It has the following structural formula:
Molecular Weight: 404.50 Molecular Formula: C23H32O6
Each gram of the cream contains: 10 mg Hydrocortisone Acetate, USP in a water-washable cream base containing carbomer 940, cetyl alcohol, edetate disodium, isopropyl myristate, isopropyl palmitate, perfume, polypropylene 26 oleate, propylene glycol, purified water, sodium lauryl ether, sodium metabisulfite, stearic acid, trolamine, urea (10%) and xanthan gum.
Sources
U-cort Manufacturers
-
Taro Pharmaceuticals U.s.a., Inc.
![U-cort (Hydrocortisone Acetate) Cream [Taro Pharmaceuticals U.s.a., Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
U-cort | Taro Pharmaceuticals U.s.a., Inc.
U-cort®, (Hydrocortisone Acetate Cream USP, 1%) is generally applied to the affected area as a thin film two to four times daily, depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropri-ate antimicrobial therapy instituted.
Login To Your Free Account